Top Medical News
Pearl Toh, 2 hours ago
Use of virtual reality (VR) helps reduce pain during childbirth, and may present a novel nonpharmacologic approach to controlling labour pain, suggests a study presented at SMFM 2020 Annual Pregnancy Meeting in Grapevine, Texas, US.
3 hours ago
Treatment with the selective inhibitor of Janus kinase 1 and 2 ruxolitinib leads to quick and stable improvements in atopic dermatitis symptoms, reports a recent phase II study.
Roshini Claire Anthony, 7 hours ago

Many children in Singapore may not be vaccinated according to the national recommended immunization schedule, with maternal age, ethnicity, household income, and number of siblings among the factors influencing non-adherence, according to findings from the GUSTO* study.

8 hours ago
Stage 1 hypertension, based on the revised American Heart Association guidelines, exerts adverse effects on pregnancy outcomes, especially in women with prepregnancy normal weight, as suggested in a recent study.
8 hours ago
Ticagrelor plus acetylsalicylic acid (aspirin) demonstrates comparable antithrombotic potency to ticagrelor monotherapy in terms of ex vivo blood thrombogenicity among high-risk patients receiving drug-eluting stents, reveals a study. In contrast, markers sensitive to cyclo-oxygenase-1 blockade are higher in the absence of aspirin.
Stephen Padilla, 9 hours ago
A wearable, hermetically sealed high-precision vibration sensor enables simultaneous monitoring of multiple health factors associated with the cardiopulmonary system, including heart and respiratory rates, heart sounds, lung sounds, and body motion and position of an individual, a study shows.
10 hours ago
Neonates with hypoxic-ischaemic encephalopathy (HIE) who are treated with therapeutic hypothermia after perinatal sentinel events experience less severe injury on brain magnetic resonance imaging (MRI) following rewarming, a study has shown. Motor and language outcomes also improve at 18–36 months.
Special Reports
17 Feb 2020
 At a recent symposium, prominent endocrinologist Emeritus Professor Dato’ Mustaffa Embong discussed the role of vitamin B12 in the treatment of diabetic neuropathy.
Pank Jit Sin, 28 Jan 2020

The interest in healthcare and medicine is evident from companies in fields unrelated to healthcare venturing into the scene. With this interest is the boom of healthcare facilities, both clinics and hospitals, being set up in the country. As of end 2017, Malaysia counted 200 private hospitals with 14,799 beds. [, Accessed on 18 November]

The recent launch of Sunway Medical Centre Velocity (SMCV) coincides with the boom of hospitals established in the country. However, its founding should not be seen as jumping on the bandwagon. Rather, the hospital is a carefully planned and executed venture. MIMS spoke to SMCV’s Chief Executive Officer, Wilson Choo, to get his insights on the establishment of SMCV and his vision for SMCV in the short and long term.

23 Jan 2020
Bumrungrad International Hospital was founded in 1980 and has since grown to become one of the most reputable hospitals in the region. The recipient of numerous international awards and accreditations, Bumrungrad International is one of the largest private hospitals in Southeast Asia, catering to over 1.1 million patients from over 190 countries annually.

In an exclusive interview with MIMS, Kenny Lim, Chief Information Technology Officer of Bumrungrad International Hospital shared his views on how the hospital has continued to improve its services to patients with particular emphasis on the use of clinical decisions support tools.
09 Jan 2020
In collaboration with the Malaysian Society of Infectious Diseases and Chemotherapy,Sanofi Pasteur Malaysia commemorated the launch of VaxigripTetra® by inviting three distinguished speakers to provide valuable insights into the prevalence of influenza and how vaccination can truly impact the health status of patients in general.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
23 Dec 2019
At a recent Pfizer-sponsored symposium, held in conjunction with the 17th Urological Association of Asia Congress at Kuala Lumpur Convention Centre, Professor Bannakij Lojanapiwat gave a lecture on the pathophysiology and management of overactive bladder (OAB) and lower urinary tract symptoms (LUTS), highlighting the importance of individualised pharmacological intervention in optimizing patient outcomes.
10 Dec 2019
Oral H1-antihistamines are the initial treatment of choice for allergic rhinitis (AR) and chronic urticaria in the primary care setting. However, in a diverse population of patients with AR and urticaria, primary care physicians are faced with the challenge of prescribing the best therapy amid a wide armamentarium of antihistamines available.
Conference Reports
Roshini Claire Anthony, 17 Feb 2020

Neoadjuvant chemotherapy with S-1 and oxaliplatin (SOX) may be a suitable treatment measure for patients with advanced gastric or esophagogastric junction adenocarcinoma, according to the RESONANCE* trial presented at ASCO GI 2020.

Pearl Toh, 14 Feb 2020
Donor selection for faecal microbiota transplant (FMT) can make a difference to maintenance of long-term remission in patients with ulcerative colitis (UC), reveals a study presented at the 2020 Crohn's & Colitis Congress (CCC).
Pearl Toh, 13 Feb 2020
Dose escalation of ustekinumab appears to be an effective option for Crohn’s disease (CD) patients with luminal and perianal manifestations who were nonresponsive to previous therapies, according to a study presented at the Crohn's & Colitis Congress (CCC) 2020.
Roshini Claire Anthony, 13 Feb 2020

The humanized monoclonal antibody mirikizumab appears to reduce bowel movement urgency among patients with moderate to severely active ulcerative colitis (UC), according to a study presented at the Crohn’s and Colitis Congress 2020.

Pearl Toh, 12 Feb 2020
Vedolizumab was similarly effective as infliximab in the control of arthralgias in patients with inflammatory bowel disease (IBD) in the real world, suggests a head-to-head study presented at the Crohn's & Colitis Congress (CCC) 2020.
Roshini Claire Anthony, 12 Feb 2020

Children with inflammatory bowel disease (IBD) do not appear to have an elevated risk of lymphoma following treatment with anti-tumour necrosis factor (TNF) agents, according to a study presented at the recent Crohn’s and Colitis Congress 2020.

Christina Lau, 10 Feb 2020

Adding pegilodecakin, a pegylated form of interleukin-10 (IL-10), to second-line FOLFOX chemotherapy does not significantly improve overall survival (OS) or other outcomes in patients with advanced pancreatic ductal adenocarcinoma (PDAC) as compared with FOLFOX alone, results of the phase III SEQUOIA trial have shown.

CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download